NCT01105559View on ClinicalTrials.gov

Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine

CompletedOBSERVATIONAL
Enrollment

455

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2011

Conditions
DiphtheriaTetanusWhooping CoughHepatitis BPoliomyelitis
Trial Locations (2)

2013

Bertsham

Unknown

Johannesburg

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY